Brigatinib

Definition: Brigatinib, sold under the brand name Alunbrig among others, is a small-molecule targeted cancer therapy being developed by Ariad Pharmaceuticals, Inc. Brigatinib acts as both an anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR) inhibitor. source: Wikipedia

ID

774906001

Name

Brigatinib

Previous ID

36594411000001104

ID date

6 Feb 2023